1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow erdosteine: new trials by email Literature Review of erdosteine trials Research Report on erdosteine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immuno-inflammatory Response of Erdosteine in COPD Erdosteine, Standard of Care (SOC) - COPD | Not applicable | Not yet recruiting | Pierachille Santus, MD, PhD | 30 | 2026-09-01 | 2026-04-29 |
| Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary Disease Muco-active agents, No muco-active agent use - Lung Cancer (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD) | Active not recruiting | Seoul National University | 27000 | 2026-06-01 | 2026-07-21 | |
| Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease Standard Therapy, Erdosteine - Fatty Liver | Phase 1 / Phase 2 | Recruiting | Tanta University | 50 | 2025-11-20 | 2025-12-10 |
| Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Erdosteine, Placebo - Chronic Obstructive Pulmonary Disease | Phase 4 | Withdrawn | Hull University Teaching Hospitals NHS Trust | 2010-08-10 | 2019-06-19 | |
| The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD) Erdosteine, Placebo - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Unknown | Edmond Pharma | 492 | 2009-08-01 | 2014-06-13 |
| Phase 2 Study - Erdosteine in Patients With CB/COPD Erdosteine - Chronic Bronchitis, Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Adams Respiratory Therapeutics | 400 | 2006-03-01 | 2007-12-06 |
Pulmonary Disease, Chronic Obstructive (5) · Bronchitis, Chronic (1) · Cough (1) · Disease (1) · Disease Progression (1) · Fatty Liver (1) · Lung Neoplasms (1)
Adams Respiratory Therapeutics (1) · Edmond Pharma (1) · Hull University Teaching Hospitals NHS Trust (1) · Pierachille Santus, MD, PhD (1) · Seoul National University (1) · Tanta University (1)
Italy (2) · United Kingdom (2) · Belgium (1) · Bulgaria (1) · Czechia (1) · Denmark (1) · Egypt (1) · France (1) · Poland (1) · Romania (1) · Slovakia (1) · South Korea (1) · United States (1)
Alyn H Morice, FRCP (1) · Helmut Albrecht, MD (1) · Hyun Woo Lee, MD, PhD (1) · Jiyu Sun (1)